| Business Summary |
| A biopharmaceutical company, which is engaged in the discovery, development and delivery of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states. |
| General Information |
352 Knotter Drive
Cheshire, CT 06410
|
| www.alexionpharm.com |
| Industry : Drugs |
| Sector: Health Care |
| Employees: 504 |
| CEO: Dr. Leonard Bell, M.D. |
| Short Interest |
| Current Month (Mil) |
3.87 |
| Previous Month (Mil) |
4.28 |
| Short Interest Ratio (Days) |
4.50 |
| Management Effectiveness |
| Return on Equity |
17.20 |
| Return on Assets |
13.30 |
| Return on Investments |
16.80 |
| Profitability |
| Gross Margin |
92.10 |
| EBIT Margin |
22.20 |
| Profit Margin |
20.80 |
Connect with TheStreet